Skip to Content

Welcome to DrugSense

This is a web portal for DrugSense - Media Awareness Project (MAP) - Drug Policy Central (DPC)

Donate Now!DrugSense is an award winning (501)(c)(3) non-profit organization incorporated in 1995 to inform citizens and encourage involvement in drug policy reform.

It has developed a number of projects and services that have become a foundation for drug policy reform. The Media Awareness Project (MAP) Drug News Archive encourages unbiased media coverage, online media activism and a drug policy research tool. Drug Policy Central's Web-based services provides subsidized technical services for drug policy organizations organization to empower their members to organize and share information and resources.   Read more

Drug War Clock

Time 
Federal 
State 
Total 
Arrests 

Request for Support for DrugSense and MAP Inc.

Dear Drug Policy Reform Supporter,

We at DrugSense and MAPinc hope you have are having a prosperous and enjoyable 2019 that continues through the coming year.

As has been the case for many years, continued support of DrugSense/MAP Inc. has been a vital factor in what we consider to be one of the best investments in the drug policy reform effort that we are aware of. On a relatively small budget, we continue to provide an impressive array of features and support for a wide ranging group of organizations and individuals that are active throughout the drug policy reform arena.

Hopefully this report will provide something of an overview of what DrugSense/MAP inc. has been doing for the reform community for more than 25 Years!

Over the years, we have evolved into a very multifaceted organization. This makes it difficult to concisely enumerate all of the many and varied services we provide the drug policy reform community but, hopefully, I can provide a pretty convincing overview without taking too much of your time.



News

US NY: New York Decriminalises Use Of Cannabis
New York has decriminalised the use of marijuana - becoming the 16th US state to do so. The move, which would make possession of a small amount of the drug a violation rather than a felony, was signed into law by governor Andrew Cuomo.
US: Mark Kleiman, Policy Expert Who Fought To Lift Marijuana Ban
Mark A. R. Kleiman, a prominent drug policy apostate who favored what he viewed as a sensible middle ground on marijuana - eliminate criminal sanctions for selling and using it but preclude full-blown commercial legalization - died on Sunday in Manhattan. He was 68.
US: Where Legal, Pot Still Closes Doors To Hiring
Smoking pot cost Kimberly Cue her job. Ms. Cue, a 44-year-old chemical engineer from Silicon Valley, received an offer this year from a medical device manufacturer only to have it rescinded when the company found out that she smoked prescription marijuana to treat post-traumatic stress disorder.
US: Colleges Offer Degree, Courses In Pot Business
Two major universities are creating the first career paths for young people interested in the business of marijuana.

Opinions

CN BC: Editorial: Abstinence Works Best
More than half of all Canadians believe drug treatment should focus on abstinence, rather than opioid replacement therapies, according to poll results released this week.
CN BC: Legalizing Pot Is Proving To Be A Public-Health
It's becoming increasingly obvious that legalizing marijuana consumption was a colossal public-health blunder.
UK: The Guardian View On The Case For Legalising Drugs:
Drug laws should be designed to minimise damage. This might sound obvious. But the UK's drug laws - along with those of most other countries - arguably do not have this effect. Indeed there is a strong argument that in many respects the blanket prohibition, under criminal statutes, of substances from cannabis to heroin along with the myriad synthetic substances now widely used to mimic their effects, does more harm than good.
Canada: Oped: The Unbearable Whiteness Of Weed
The Canadian cannabis industry is booming. From giant industrial operations such as Canopy Growth to smaller "luxury"=9D cannabis retailers, to an array of cannabis "lifestyle"=9D brands and "cannabis brand consultancy"=9D firms, the industry is a lucrative fronti er for those seeking wealth in a rapidly growing market.

Letters

CN BC: Harm Reduction Is First Aid
Dear Editor: Contrary to Joe Fries' editorial "Abstinence works best" (Courier, Aug. 16), Rhode Island treats addicted prison inmates with methadone, buprenorphine and naltrexone. Like methadone, buprenorphine is an opioid agonist, or replacement opioid. Naltrexone is an opioid antagonist that blocks opioid receptors.
CN BC: On Cannabis, Canada Is Different From Colorado
Re: "Legalizing pot is proving to be a public-health disaster," column, Aug. 11. In his opinion piece on cannabis legalization, Lawrie McFarlane cites a short-term increase in the numbers of adolescents visiting emergency rooms for cannabis in Colorado - a jurisdiction with a commercialized approach to cannabis legalization - as evidence that Canada's much more restrictive public health-oriented approach to legalization has failed.
CN BC: Too Soon For A Verdict On Pot Legalization
Re: "Legalizing pot is proving to be a public-health disaster," column, Aug. 11. Lawrie McFarlane's verdict is premature. Legal regulation in Canada isn't analogous to legalization in Colorado, for among other reasons, Colorado allows advertising and initially allowed edibles and extracts with inadequate labelling, packaging and dose limitations.
US: Legal Marijuana Is Nowhere Near A High Point
Alex Berenson's allegation that public support for marijuana law reform is waning ("Marijuana Activists Pass Their High Point," op-ed, June 26) is nothing short of a pipe dream.
US: Regulate Marijuana Sales
Re "Marijuana Damages Young Brains," by Kenneth L. Davis and Mary Jeanne Kreek (Op-Ed, June 17): No one is advocating that young people either consume or have ready access to cannabis. In fact, it is precisely because marijuana use may pose potential risks to certain consumers - for example, adolescents or people with a family history of psychiatric illness - that NORML believes that lawmakers should regulate it accordingly.
US MA: Marijuana No Barrier To Safe Driving
To the editor: Your June 28 editorial, "Marijuana-impaired drivers a growing danger," lacks a rational basis for crying wolf. In fact, marijuana consumption's negligible impact on driving ability pales next to alcohol and distraction by smartphone use.
US: What Failure?
According to Messrs. Kennedy and Sabet, cannabis legalization is "a failed experiment." But in Washington state, which like Colorado legalized in 2012, support has increased from 56% to an astounding 78%. Some failure!